Labshake search
Citations for Qiagen :
1 - 50 of 701 citations for Protein Crystallization since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Biochemistry 2021Quote: ... Protein crystallization was screened for in commercially available screens (Qiagen), using a Crystal Gryphon robot (Art Robbins Instruments) ...
-
bioRxiv - Microbiology 2019Quote: ... Initial crystallization conditions were obtained with the Protein Complex Suite (Qiagen) screened by sitting drop-vapor diffusion at 18 °C using a Mosquito robot and were optimized in hanging drops by mixing 1 μL of the sample with 1 μL of the precipitant ...
-
bioRxiv - Biophysics 2021Quote: ... in standard crystallization screens (QIAgen) using a mosquito protein crystallisation robot (sptlabtech) ...
-
bioRxiv - Biophysics 2024Quote: DR2539 truncated protein was initially screened by the following commercial crystallization screens: Classics Suite (Qiagen), Salt grid (Hampton Research) ...
-
bioRxiv - Biophysics 2020Quote: ... we carried out initial crystallization trials in 15-well hanging drop format using EasyXtal crystallization plates (Qiagen) and a crystallization screen that was designed to explore the chemical space around the crystallization conditions reported by Blomberg et al.15 Crystallization drops were prepared by mixing 1 μL of protein solution with 1 μL of the mother liquor ...
-
bioRxiv - Biochemistry 2019Quote: Screening of crystallization conditions was performed using a Mosquito drop dispensing automate (TTPLabtech) and crystallization screens (Qiagen). Drops were prepared by mixing 150 nL of protein solution with an equivalent volume of screening solution ...
-
bioRxiv - Biochemistry 2023Quote: ... we carried out initial crystallization trials in 15-well hanging drop format using EasyXtal crystallization plates (Qiagen) and a crystallization screen that was designed to explore the chemical space around the crystallization conditions reported by Broom et al.14 Crystallization drops were prepared by mixing 1 μL of protein solution with 1 μL of the mother liquor and sealing the drop inside a reservoir containing an additional 500 μL of the mother liquor solution ...
-
bioRxiv - Biochemistry 2022Quote: ... or 0.2 or 0.4 μL of the protein solution and 0.2 μL of a series of commercially available crystallization screens (Qiagen). Conditions that provided initial hits were optimized using bespoke screens prepared at the crystallization facility ...
-
bioRxiv - Immunology 2021Quote: ... and subsequent crystallization optimization was performed manually using hanging-drop vapor diffusion method with 15-well screw-cap crystallization plates (Qiagen). The H5.28-HA head complex was crystallized in 7-9% PEG 8000 ...
-
bioRxiv - Biochemistry 2023Quote: ... the initial crystallization screening was performed using the sitting-drop vapor-diffusion method with Screen classics and Classics II crystallization kits (Qiagen, Hilden, Germany) and PACT kits (Molecular Dimensions ...
-
bioRxiv - Biochemistry 2019Quote: ... Initial conditions were obtained in classics suite crystallization screen (Qiagen), solution 36 ...
-
bioRxiv - Immunology 2020Quote: Crystallization conditions were screened using the PEGs II suite (Qiagen) at 20°C ...
-
bioRxiv - Biochemistry 2022Quote: ... crystallization solutions and consumable were purchased from Qiagen (Hilden, Germany), Hampton Research (Aliso Viejo ...
-
bioRxiv - Biochemistry 2020Quote: ... Initial conditions were obtained in the Classics lite crystallization screen (Qiagen), solution 1 ...
-
bioRxiv - Biochemistry 2020Quote: Crystallization conditions were screened using commercially available sparse-matrix screens (Qiagen) and a protein concentration of 4.7 mg mL−1 ...
-
bioRxiv - Systems Biology 2021Quote: Crystallization conditions were screened using commercially available (Qiagen, Hampton Research, Emerald Biosystems) and in-house developed kits by the sitting-drop vapor-diffusion method in 96-well MRC 2-drop plates (SWISSCI ...
-
bioRxiv - Biochemistry 2020Quote: ... Crystallization screening was performed at 4°C with JCSG core I (Qiagen) using the sitting drop vapor diffusion method ...
-
bioRxiv - Microbiology 2019Quote: Initial crystallization conditions were identified with a sparse matrix screen (MPD Suite, Qiagen) by vapor diffusion in sitting drops on a Cartesian crystallization robot ...
-
bioRxiv - Biophysics 2024Quote: ... The complex was initially screened by the following commercial crystallization screens: Nucleix (Qiagen) and Wizard I&II (Rigaku reagents) ...
-
bioRxiv - Biochemistry 2020Quote: Purified CrTRXz was tested for crystallization on commercial sparse-screening conditions (Qiagen, Hilden Germany) of the Joint Center for Structural Genomics screens [97] with a mixture of 30 nL protein and 30 nL precipitant equilibrated against a reservoir volume of 30 µL mother liquor ...
-
bioRxiv - Bioengineering 2020Quote: ... Crystallization screening was performed in multiple 96-condition spare matrix suites available from Qiagen or Hampton Research ...
-
bioRxiv - Biochemistry 2020Quote: ... Initial crystallization conditions were identified with commercial sparse matrix screens JCSG+ (Qiagen, Hilden, Germany), Index (Hampton Research ...
-
bioRxiv - Microbiology 2019Quote: eGacH crystallization conditions were initially screened using the JCSG Suites I–IV screens (Qiagen) at a protein concentration of 9 mg/mL by hanging drop vapor diffusion method ...
-
bioRxiv - Microbiology 2020Quote: ... vapor-diffusion crystallization trials were conducted using the JCSG Core I-IV screens (Qiagen), setup using a Mosquito Crystal (TTP ...
-
bioRxiv - Immunology 2021Quote: ... Each complex was screened for crystallization using the 384 conditions of the JCSG Core Suite (Qiagen) and ProPlex screen (Molecular Dimensions ...
-
bioRxiv - Microbiology 2019Quote: ... crystallization was performed by the hanging drop vapor diffusion method using EasyXtal 15-Well Tools (QIAGEN). CCDP15 proteins carrying A128T ...
-
bioRxiv - Microbiology 2021Quote: ... crystallization was performed by the hanging-drop vapor diffusion method using EasyXtal 15-well tools (QIAGEN). CA-NTD 1-146/Δ87-99G proteins were expressed and purified as described above ...
-
bioRxiv - Biochemistry 2021Quote: Crystallization conditions were screened using commercially available and in-house developed kits (Qiagen, Hampton Research, Emerald Biosystems) by the sitting-drop vapor-diffusion method in 96-well MRC 2-drop plates (SWISSCI ...
-
bioRxiv - Microbiology 2021Quote: ... 14 mg/ml) were screened for crystallization using the 384 conditions of the JCSG Core Suite (Qiagen) on our custom-designed robotic CrystalMation system (Rigaku ...
-
bioRxiv - Microbiology 2020Quote: ... The Fab/RBD complexes were screened for crystallization using 384 conditions of the JCSG Core Suite (QIAGEN) on our robotic CrystalMation system (Rigaku ...
-
bioRxiv - Molecular Biology 2020Quote: ... The complex was initially crystallized in a buffer 0.1 M MES pH 6.5 and 0.6 M sodium fluoride from Anions Suite crystallization screen (Qiagen). After optimization of crystallization conditions ...
-
Structural and mechanistic insights into disease-associated endolysosomal exonucleases PLD3 and PLD4bioRxiv - Biochemistry 2023Quote: mPLD3 and hPLD4 were screened for crystallization using the 384 conditions of the JCSG Core Suite (Qiagen) on our robotic CrystalMation system (Rigaku ...
-
bioRxiv - Biochemistry 2020Quote: CYP124 was crystallized using a sitting drop approach in 96-well crystallization plates with commercially available kits (Qiagen) at 20 °C with 1:1 protein/mother liquor ratio with the ligand concentration of 100 μM ...
-
bioRxiv - Biochemistry 2023Quote: Initial crystallization conditions were identified utilizing hanging drop vapor diffusion with the Classics II and ProComplex screens (QIAGEN). The best crystals were obtained by equilibrating a 0.6 μL drop at 12 mg/mL of the complex of ARL15 (32-197 ...
-
bioRxiv - Bioengineering 2021Quote: ... The complex (12 mg/ml) was screened for crystallization using the 384 conditions of the JCSG Core Suite (Qiagen) on our custom-designed robotic CrystalMation system (Rigaku ...
-
bioRxiv - Biochemistry 2020Quote: CYP124–SQ109 was crystallized by a sitting drop approach in 96-well crystallization plates with commercially available kits (Qiagen) at 20 °C with 1:1 protein/mother liquor ratio with the ligand concentration of 100 μM ...
-
bioRxiv - Microbiology 2020Quote: ... The complex (7.5 mg/ml) was screened for crystallization using the 384 conditions of the JCSG Core Suite (Qiagen) on our custom-designed robotic CrystalMation system (Rigaku ...
-
bioRxiv - Immunology 2023Quote: ... The protein complexes were adjusted to 8.6–12 mg/ml and screened for crystallization using the 384 conditions of the JCSG Core Suite (Qiagen) on our robotic CrystalMation system (Rigaku ...
-
bioRxiv - Microbiology 2020Quote: ... protein were adjusted to around 11 mg/mL and screened for crystallization using the 384 conditions of the JCSG Core Suite (Qiagen) on our custom-designed robotic CrystalMation system (Rigaku ...
-
bioRxiv - Microbiology 2020Quote: ... Each complex was adjusted to 12 mg/ml and screened for crystallization using the 384 conditions of the JCSG Core Suite (Qiagen) on our custom-designed robotic CrystalMation system (Rigaku ...
-
bioRxiv - Microbiology 2021Quote: ... The protein complex was adjusted to 12 mg/ml and screened for crystallization using the 384 conditions of the JCSG Core Suite (Qiagen) on our robotic CrystalMation system (Rigaku ...
-
bioRxiv - Immunology 2021Quote: ... The protein complex was adjusted to 14 mg/ml and screened for crystallization using the 384 conditions of the JCSG Core Suite (Qiagen) on our robotic CrystalMation system (Rigaku ...
-
bioRxiv - Microbiology 2020Quote: ... Each complex was adjusted to 13 mg/ml and screened for crystallization using the 384 conditions of the JCSG Core Suite (Qiagen) and ProPlex screen (Molecular Dimensions ...
-
bioRxiv - Microbiology 2022Quote: ... The protein complex was adjusted to 12 mg/ml and screened for crystallization using the 384 conditions of the JCSG Core Suite (Qiagen) on our robotic CrystalMation system (Rigaku ...
-
bioRxiv - Immunology 2022Quote: ... The protein complex was adjusted to 11 mg/ml and screened for crystallization using the 384 conditions of the JCSG Core Suite (Qiagen) on our robotic CrystalMation system (Rigaku ...
-
bioRxiv - Biochemistry 2023Quote: ... Crystals were grown at 30°C by the hanging drop vapor diffusion method using 2 μL sample drops and 300 μL crystallization solution in a sealed chamber (EasyXtal 15-Well Tool, Qiagen). Crystals were soaked for 1h (for the Na structure or with the dibromo Intronistat B derivative ...
-
bioRxiv - Biochemistry 2024Quote: ... Initial screening was conducted using the sitting-drop vapor diffusion method with the ARI Crystal Gryphon Robot (ARI) and crystallization screening kits (QIAGEN) at 18°C ...
-
bioRxiv - Biochemistry 2021Quote: Purified CrFBA3 was tested for crystallization at two concentration of 9 mg/ml and 4.5 mg/ml on commercial sparse-screening conditions (Qiagen, Hilden Germany) based on the work of Jancarik and Kim (Jancarik ...
-
bioRxiv - Immunology 2020Quote: Initial crystallization hits were obtained via sparse matrix screening in 96-well plates using commercially available crystallographic solutions (Qiagen, Toronto, ON). Optimization of crystallization conditions was performed in 24-well plate format using the hanging drop vapor diffusion method ...
-
bioRxiv - Biochemistry 2022Quote: 100 nL of pure CrRPE1 concentrated at 9.5 mg mL−1 were mixed with 100 nL of each of the 384 precipitant conditions of the joint center for structural genomics sparse-matrix screen for crystallization (Qiagen, Hilden, Germany) (Lesley and Wilson 2005) ...